Characterization of dicarboxylic salts of protonated triethylenetetramine useful for the treatment of copper-related pathologies

Crystal Growth and Design

Volumn 7, Issue 9, 2007, Pages 1844-1850

  Wichmann, Kathrin A ^a   Boyd, Peter D W ^a   Söhnel, Tilo ^a   Allen, Grant R ^a   Phillips, Anthony R J ^b   Cooper, Garth J S ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34748916511     PISSN: 15287483     EISSN: None     Source Type: Journal    
DOI: 10.1021/cg0704549     Document Type: Conference Paper

References (57)

1. (a) Bianchi, A., Bowman-James, K., Garcia-España, E., Eds. Supramolecular Chemistry of Anions; Wiley-VCH: New York, 1997.
2. (b) Schmidtchen, F. P.; Berger, M. Chem. Rev. 1997, 97, 1609-1646.
3. (c) Gale, P. A. Coord. Chem. Rev. 2003, 240, 191-221.
4. (d) Sessler, J. L.; Gale, P. A.; Cho, W.-S. Anion Receptor Chemistry; RSC Publishing: Cambridge, 2006.
5. (e) Junk, P. C.; Smith, M. K. C. R. Chim. 2005, 8, 189-198.
6. (f) Kubik, S.; Reyheller, C.; Stüwe, S. J. Inclusion Phenom. Macrocyclic Chem. 2005, 52, 137-187.
7. (g) Bianchi, A.; Micheloni, M.; Paoletti, P. Coord. Chem. Rev. 1991, 110, 17-113.
8. (h) Llinares, J. M.; Powell, D.; Bowman-James, K. Coord. Chem. Rev. 2003, 240, 57-75.
9. (i) Llinares, J. M.; BowmanJames, K. In Encyclopedia of Supramolecular Chemistry; Atwood, J. L., Steed, J. W., Eds.; Marcel Dekker: New York, 2004; p 1170.
10. (j) Lehn, J. M., Ed. Supramolecular Chemistry, Concepts and Perspectives; VCH: Weinheim, Germany, 1995.
11. (k) Daniele, P. G.; Prenesti, E.; De Robertis, A.; De Stefano, C.; Foti, C.; Giuffre, O.; Sammartano, S. Ann. Chim. (Rome) 1997, 87, 415-447.
12. (l)Llinares, J. M.; Powell, D.; Bowman-James, K. Coord. Chem. Rev. 2003, 240, 57-75.
13. (m) Garcia-Espana, E.; Diaz, P.; Llinares, J. M.; Bianchi, A. Coord. Chem. Rev. 2006, 250, 2952-2986.
14. (n) Ilioudis, C. A.; Tocher, D. A.; Steed, J. W. J. Am. Chem. Soc. 2004, 126, 12395-12402.
15. (a) Childs, A. C.; Mehta, D. J.; Gerner, E. W. Cell. Mol. Life Sci. 2003, 60, 1394-1406.
16. (b) Løvaas, E. Adv. Pharmacol. 1997, 38, 119-149.
17. (c) Tabor, C. W.; Tabor, H. Annu. Rev. Biochem. 1984, 53, 749-790.
18. (a) Gong, D.; Lu, J.; Chen, X.; Choong, S. Y.; Zhang, S.; Chan, Y.-K.; Glyn-Jones, S.; Gamble, G. D.; Phillips, A. R. J.; Cooper, G. J. S. Mol. Pharmacol. 2006, 70, 2045-2051.
19. (b) Cooper, G. J. S.; Phillips, A. R. J.; Soon, Y. C.; Leonard, B. L.; Crossman, D. J.; Brunton, D. H.; Saafi, E. L.; Dissanayake, A. M.; Cowan, B. R.; Young, A. A.; Occleshaw, C. J.; Chan, Y.-K.; Leahy, F. E.; Keogh, G. F.; Gamble, G. D.; Allen, G. R.; Pope, A. J.; Boyd, P. D. W.; Poppitt, S. D.; Borg, T. K.; Doughty, R. N.; Baker, J. R. Diabetes 2004, 53, 2501-2508.
20. Jüllig, M.; Chen, X.; Hickey, A. J.; Crossman, D. J.; Xu, A.; Wang, Y.; Greenwood, D. R.; Choong, Y. S.; Schönberger, S. J.; Middleditch, M. J.; Phillips, A. R. J.; Cooper, G. J. S. Proteomics Clin. Appl. 2007, 1, 387-399.
21. (a) Cooper, G. J. S.; Chan, Y.-K.; Dissanayake, A. M.; Leahy, F. E.; Keogh, G. F.; Frampton, C. M.; Gamble, G. D.; Brunton, D. H.; Baker, J. R.; Poppitt, S. D. Diabetes 2005, 54, 1468-1476.
22. (b) Lu, J.; Chan, Y.-K.; Gamble, G. D.; Poppitt, S. D.; Othman, A. A.; Cooper, G. J. S. Drug Metab. Dispos. 2007, 35, 221-227.
23. (a) Dahlman, T.; Hartvig, P.; Lofholm, M.; Nordlinder, H.; Loof, L.; Westermark, K. Q. J. Med. 1995, 88, 609-616.
24. (b) Sone, K.; Maeda, M.; Wakabayashi, K.; Takeichi, N.; Mori, M.; Sugimura, T.; Nagao, M. Hepatology 1996, 23, 764-770.
25. (c) Haslam, R. H.; Sass-Kortsak, A.; Stout, W.; Berg, M. Dev. Pharmacol. Ther. 1980, 1, 318-324.
26. (d) Walshe, J. M. Lancet 1982, 1, 643-647.
27. (a) Ilioudis, C. A.; Hancock, K. S. B.; Georganopoulou, D. G.; Steed, J. W. New J. Chem. 2000, 24, 787-798.
28. (b) Ilioudis, C. A.; Georganopoulou, D. G.; Steed, J. W. CrystEngComm 2002, 4, 26-36.
29. (c) Ilioudis, C. A.; Steed, J. W. J. Supramol. Chem. 2003, 1, 165-187.
30. (a) Elaoud, Z.; Kamoun, S.; Mhiri, T.; Jaud, J. J. Chem. Crystallogr. 1999, 29, 541-545.
31. (b) Elaoud, Z.; Kamoun, S.; Mhiri, T. J. Chem. Crystallogr. 1999, 29, 1287-1290.
32. (c) Fu, Y.-L.; Xu, Z.-W.; Ren, J.-L.; Ng, S. W. Acta Crystallogr., Sect. E 2005, E61, o774-o775.
33. Fujito, H.; Tasaki, M.; Mori, M.; Takata, K. Yakuzaigaku 1990, 50, 402-408.
34. Jonas, M.; Vaulont, I.; Soi, A.; Schmidt, G. U.S. Patent Appl. 20060041170, 2006.
35. SAINT: Area-Detector Integration Software; Siemens Industrial Automation, Inc.: Madison, WI, 1995.
36. Farrugia, L. J. J. Appl. Crystallogr. 1999, 32, 837.
37. Sheldrick, G. M. SHELX97, release 97-2: Programs for Crystal Structure Analysis. Universität Göttingen, Göttingen, Germany, 1998.
38. Berndt, M.; Brandenburg, K.; Putz H. DIAMOND - Visual Crystal Structure Information System; Crystal Impact: Bonn, Germany, 1996.
39. Sluis, P. v. d.; Spek, A, L. Acta Crystallogr., Sect. A 1990, 46, 194.
40. (a) Spek, A. L. Acta Crystallogr., Sect. A 1990, 46, C34.
41. (b) Spek, A. L. PLATON, A Multipurpose Crystallographic Tool. Utrecht University, Utrecht, The Netherlands, 1998.
42. OECD Screening Information Data Set (SIDS), Initial Assessment Report for Triethylenetetramine (CAS No. 112-24-3); SIAM 8: Paris, France, 28-30 October 1998.
43. Junk, P. C.; Smith, M. K. C. R. Chim. 2005, 8, 189-198.
44. (a) Lohani, S.; Grant, D. J. W. In Polymorphism; Hilfiker, R., Ed.; Wiley-VCH: Weinheim, 2006, p 21.
45. (b) Banerjee, R.; Bhatt, P. M.; Kirchner, M. T.; Desiraju, G. R. Angew. Chem., Int. Ed. 2005, 44, 2515-2520.
46. (c) Bhatt, P. M.; Ravindra, N. V.; Banerjee, R.; Desiraju, G. R. Chem Commun. 2005, 8, 1073-1075.
47. (d) Bernstein, J., Ed. Polymorphism in Molecular Crystals; Oxford University Press: Oxford, U.K., 2002.
48. (e) Davey, R. J. Chem Commun. 2003, 1463-1467.
49. (f) Remenar, J. F.; Morissette, S. L.; Peterson, M. L.; Moulton, B.; MacPhee, J. M.; Guzman, H. R.; Almarsson, O. J. Am. Chem. Soc. 2003, 125, 8456-8459.
50. (g) Reutzel-Edens, S. M.; Bush, J. K.; Magee, P. A.; Stephenson, G. A.; Bym, S. R. Cryst. Growth Des. 2003, 3, 897-907.
51. (h) Caira, M. R.; de Vries, E. J. C.; Nassimbeni, L. R. Chem. Commun. 2003, 2058-2059.
52. (i) Bauer, M. S.T.P. Pharma Prat. 2004, 14, 281-291.
53. (a) Brittain, H. G., Ed. Polymorphism in Pharmaceutical Solids; Marcel Dekker Inc.: New York, 1999.
54. (b) Vippagunta, S. R.; Brittain, H. G.; Grant, D. J. W. Adv. Drug. Delivery Rev. 2001, 48, 3-26.
55. (c) Thorat, B. N.; Pandit, A. B.; Jangam, S. V. Chem Ind. Dig. 2005, 18, 39-44.
56. (d) Vishweshwar, P.; McMahon, J. A.; Bis, J. A.; Zaworotko, M. J. J. Pharm. Sci. 2006, 95, 499-515.
57. (e) Bechtloff, B.; Nordhoff, S.; Ulrich, J. J. Cryst. Res. Technol. 2001, 36, 1315-1328.